LABATE, ANGELO
 Distribuzione geografica
Continente #
NA - Nord America 4.105
AS - Asia 2.142
EU - Europa 1.552
SA - Sud America 407
AF - Africa 42
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 6
Totale 8.274
Nazione #
US - Stati Uniti d'America 3.953
SG - Singapore 1.203
IT - Italia 596
CN - Cina 537
BR - Brasile 314
SE - Svezia 234
GB - Regno Unito 203
DE - Germania 152
CA - Canada 118
HK - Hong Kong 104
VN - Vietnam 104
EE - Estonia 91
IN - India 67
FI - Finlandia 59
RU - Federazione Russa 54
RO - Romania 29
ZA - Sudafrica 28
AR - Argentina 27
MX - Messico 26
NL - Olanda 25
JP - Giappone 23
BD - Bangladesh 20
FR - Francia 19
PL - Polonia 18
AU - Australia 17
CO - Colombia 17
IQ - Iraq 15
EC - Ecuador 13
ES - Italia 13
ID - Indonesia 13
UA - Ucraina 13
TR - Turchia 11
CL - Cile 9
PY - Paraguay 9
PE - Perù 7
SA - Arabia Saudita 7
VE - Venezuela 7
AT - Austria 6
CH - Svizzera 6
KR - Corea 6
PK - Pakistan 6
CZ - Repubblica Ceca 5
IR - Iran 5
MA - Marocco 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AE - Emirati Arabi Uniti 4
BE - Belgio 4
IE - Irlanda 4
JO - Giordania 4
KE - Kenya 4
UZ - Uzbekistan 4
BG - Bulgaria 3
GR - Grecia 3
KZ - Kazakistan 3
LT - Lituania 3
MK - Macedonia 3
UY - Uruguay 3
EU - Europa 2
JM - Giamaica 2
LU - Lussemburgo 2
MD - Moldavia 2
NG - Nigeria 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CU - Cuba 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
IL - Israele 1
KW - Kuwait 1
LC - Santa Lucia 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
PW - Palau 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TO - Tonga 1
Totale 8.274
Città #
Chandler 660
Singapore 555
Dallas 432
Santa Clara 286
Hefei 276
Milan 227
Princeton 221
Lawrence 220
London 150
Chicago 142
Ashburn 122
Wilmington 116
Munich 109
Hong Kong 100
Des Moines 80
Ottawa 75
Boardman 59
Los Angeles 49
Ho Chi Minh City 43
Turku 42
Catanzaro 40
Shanghai 37
São Paulo 30
New York 29
Rome 26
The Dalles 26
Guangzhou 25
Council Bluffs 19
Pune 19
Redwood City 19
Hanoi 18
San Francisco 18
Brooklyn 17
Helsinki 17
Johannesburg 17
Columbus 16
Norwalk 16
Redmond 16
Seattle 16
Warsaw 16
Naples 14
Tokyo 14
Beijing 13
Chennai 13
Boston 12
Mexico City 12
Montreal 12
Amsterdam 10
Atlanta 10
Charlotte 10
Shenzhen 10
Stockholm 10
Toronto 10
Augusta 9
Timisoara 9
Belo Horizonte 8
Falls Church 8
Horia 8
Phoenix 8
Rio de Janeiro 8
St Petersburg 8
Buffalo 7
Casalnuovo Di Napoli 7
Curitiba 7
Florence 7
Melbourne 7
Miami 7
Boydton 6
Lima 6
San Nicola Manfredi 6
Thái Bình 6
Bethesda 5
Brasília 5
Castiglion Fibocchi 5
Da Nang 5
Denver 5
Hanover 5
Jakarta 5
Las Vegas 5
Manchester 5
Moscow 5
New Delhi 5
Paris 5
Quito 5
Rui'an 5
San Jose 5
Taranto 5
Valmadrera 5
Washington 5
Wuhan 5
Wuxi 5
Xuzhou 5
Amman 4
Assago 4
Aversa 4
Basra 4
Berlin 4
Birmingham 4
Bologna 4
Carrara 4
Totale 4.820
Nome #
Management of psychogenic non-epileptic seizures: a multidisciplinary approach 158
Genetics of reflex seizures and epilepsies in humans and animals 135
Predictive factors of Status Epilepticus and its recurrence in patients with adult–onset seizures: A multicenter, long follow–up cohort study 124
Levetiracetam vs Lamotrigine as First-Line Antiseizure Medication in Female Patients With Idiopathic Generalized Epilepsy 116
Rating Scale for Psychogenic Non-epileptic Seizures: Scale Development and Clinimetric Testing 91
Temporal lobe abnormalities on brain MRI in healthy volunteers: a prospective case-control study 84
A brainstem hypermetabolism in a patient with essential palatal tremor: A simultaneous 18F-FDG-PET/3 T-MRI study 80
A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy 77
3-T magnetic resonance imaging simultaneous automated multimodal approach improves detection of ambiguous visual hippocampal sclerosis. 72
Erratum: Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals (The American Journal of Human Genetics (2021) 108(6) (965–982), (S0002929721001403), (10.1016/j.ajhg.2021.04.009)) 69
A Functional Genetic Variation of the 5-HTR2A Receptor Affects Age at Onset in Patients with Temporal Lobe Epilepsy 66
Neocortical thinning in “benign” mesial temporal lobe epilepsy 65
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST) 65
Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy: A consensus report from the International League Against Epilepsy Neuroimaging Task Force. 56
Asymmetry of Permutation Entropy in Early Creutzfeldt-Jakob Disease: A Clue to a Specific Pathological Process? 55
A new Italian instrument for the assessment of irritability in patients with epilepsy. 54
A puzzling case without solution: isolated late-onset epileptic seizure 52
Advanced morphological neuroimaging study in lateral temporal lobe epilepsy: A multicentric study 52
A Loss-of-Function HCN4 Mutation Associated With Familial Benign Myoclonic Epilepsy in Infancy Causes Increased Neuronal Excitability 52
A novel mutation in the Notch3 gene in an Italian family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: genetic and magnetic resonance spectroscopic findings 51
Long-term outcome of mild mesial temporal lobe epilepsy 50
Teaching NeuroImages: Pseudohypertrophic cerebral cortex in end-stage Creutzfeldt-Jakob disease 49
Age at onset predicts good seizure outcome in sporadic non-lesional and mesial temporal sclerosis based temporal lobe epilepsy 49
Facemask headache: a new nosographic entity among healthcare providers in COVID-19 era 49
A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability 49
Perampanel as first add-on choice on the treatment of mesial temporal lobe epilepsy: an observational real-life study 48
Circulating microrna: The potential novel diagnostic biomarkers to predict drug resistance in temporal lobe epilepsy, a pilot study 47
Topographic divergence of atypical cortical asymmetry and atrophy patterns in temporal lobe epilepsy 47
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures 46
Integrity of the corpus callosum in patients with benign temporal lobe epilepsy 44
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 43
Antidepressant effect of vagal nerve stimulation in epilepsy patients: a systematic review 43
Why should we change the term psychogenic nonepileptic seizures (PNES)? 42
Advanced MRI Morphologic Study Shows No Atrophy in Healthy Individuals with Hippocampal Hyperintensity 42
A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide. 42
AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives 42
A novel mutation in the notch3 gene in an Italian family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: genetic and MRI spectroscopic analyses 42
Psychopathological constellation in Psychogenic Non-Epileptic Seizures 42
Neuropsychological profile of mild temporal lobe epilepsy 41
Determinants of health-related quality of life in pharmacoresistant epilepsy: Results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments 41
Kufs disease due to mutation of CLN6: clinical, pathological and molecular genetic features. 41
Structural brain abnormalities in the common epilepsies assessed in 3,876 individuals worldwide 41
Deep Learning Representation from Electroencephalography of Early-Stage Creutzfeldt-Jakob Disease and Features for Differentiation from Rapidly Progressive Dementia. 41
Network-based atrophy modeling in the common epilepsies: A worldwide ENIGMA study 41
Hippocampal and thalamic atrophy in mild temporal lobe epilepsy: a VBM study 40
Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures 40
The impact of one-year COVID-19 containment measures in patients with mesial temporal lobe epilepsy: A longitudinal survey-based study 40
Usefulness of a morning routine EEG recording in patients with juvenile myoclonic epilepsy. 39
Gerstmann-Straussler-Scheinker disease with PRNP P102L heterozygous mutation presenting as progressive myoclonus epilepsy. 39
Diagnostic Biomarkers of Epilepsy 39
A familial t(4;8) translocation segregates with epilepsy and migraine with aura 39
White matter abnormalities across different epilepsy syndromes in adults: an ENIGMA-Epilepsy study 39
Clinical utility of home videos for diagnosing epileptic seizures: a systematic review and practical recommendations for optimal and safe recording 39
Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes 38
Association between the M129V variant allele of PRNP gene and mild temporal lobe epilepsy in women 38
Polymorphism of the multidrug resistance 1 gene MDR1/ABCB1 C3435T and response to antiepileptic drug treatment in temporal lobe epilepsy 38
Spontaneous obliteration of MRI-silent cerebral angiomatosis revealed by CT angiography in a patient with Sturge-Weber syndrome 38
Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta-analysis of risk factors 38
Value of multimodal imaging approach to diagnosis of neurosarcoidosis 38
Deep learning representation from electroencephalography of early-stage creutzfeldt-jakob disease and features for differentiation from rapidly progressive dementia 38
Anti-N-methyl-D-aspartate-glutamic-receptor encephalitis presenting as paroxysmal exercise-induced foot weakness 37
Permutation entropy of scalp EEG: A tool to investigate epilepsies: Suggestions from absence epilepsies. 37
The mystery of unexplained traumatic sudden falls. A clinical case that adds a new feasible cause 37
Brand-to-Generic Levetiracetam Switching: a four-years prospective observational real-life study 37
Blocking out the real diagnosis 37
Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study 37
The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy 36
Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective study 36
Reversible symmetrical external capsule hyperintensity as an early finding of autoimmune encephalitis. 36
White Matter Abnormalities Differentiate Severe from Benign Temporal Lobe Epilepsy. 36
Brainstem Posterior Reversible Encephalopathy Syndrome in an Asymptomatic Patient. 36
The ENIGMA-Epilepsy working group: Mapping disease from large data sets 36
Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17458 subjects 36
Artificial intelligence for classification of temporal lobe epilepsy with ROI-level MRI data: A worldwide ENIGMA-Epilepsy study 36
Acute bulbar palsy without ophtalmoplegia associated with anti-GD3 IgM antibodies. 35
Functional activity changes in memory and emotional systems of healthy subjects with déjà vu. 35
Value of clinical features to differentiate refractory epilepsy from mimics: a prospective longitudinal cohort study. 35
The parkin gene is not involved in late-onset Parkinson’s disease 35
Anti-GM1 antibodies are not associated with cerebral atrophy in patients with multiple sclerosis 35
Atlas of lesion locations and postsurgical seizure freedom in focal cortical dysplasia: A MELD study 35
Late epileptic seizures following cerebral venous thrombosis: a systematic review and meta-analysis 34
Familial mesial temporal lobe epilepsy (FMTLE): a clinical and genetic study of 15 Italian families 34
Why should we change the term psychogenic nonepileptic seizures? 34
Mutational analysis of EFHC1 gene in Italian families with juvenile myoclonic epilepsy 34
Non-paraneoplastic limbic encephalitis characterized by mesio-temporal seizures and extratemporal lesions: a case report 34
Mild Lafora disease: Clinical, neurophysiologic, and genetic findings. 34
Tacrolimus-induced polyneuropathy after heart transplantation 34
Levetiracetam in patients with generalised epilepsy and myoclonic seizures: a open label study 34
GABA(B) receptor 1 polymorphism (G1465A) is associated with temporal lobe epilepsy 34
Homozygous c.649dupC mutation in PRRT2 worsens the BFIS/PKD phenotype with mental retardation, episodic ataxia, and absences 33
Prodynorphin gene promoter polymorphism and temporal lobe epilepsy 33
Validation Study of Italian Version of Inventory for Déjà Vu Experiences Assessment (I-IDEA): A Screening Tool to Detect Déjà Vu Phenomenon in Italian Healthy Individuals 33
Tremor pattern differentiates drug-induced resting tremor from Parkinson disease. 33
Modeling epileptogenic lesions and mapping networks - Imaging genetics for benign mesial temporal lobe epilepsy 33
Cerebral venous thrombosis and isolated intracrania hypertension without papilledema in CDH 32
Bell's palsy: a manifestation of prediabetes? 32
Familial mesial temporal lobe epilepsies: clinical and genetic features 32
Psychiatric Assessment in Patients with Mild Temporal Lobe Epilepsy 32
Lamotrigine positively affects the development of psychiatric comorbidity in epileptic animals, while psychiatric comorbidity aggravates seizures 32
Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice 32
Totale 4.639
Categoria #
all - tutte 105.557
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.557


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021225 0 0 5 31 26 14 7 25 72 27 13 5
2021/2022667 14 1 0 173 66 13 13 133 81 63 105 5
2022/20231.786 448 94 44 202 207 175 4 110 271 102 107 22
2023/2024836 167 120 85 51 56 191 18 31 9 17 26 65
2024/20253.113 366 218 169 146 212 410 129 94 354 222 267 526
2025/20261.692 332 665 695 0 0 0 0 0 0 0 0 0
Totale 8.506